CLN — Celon Pharma SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Celon Pharma SA, fiscal year end - December 31st, PLN millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	228	165	115	75.1	20.6
Net Total Accounts Receivable
Net Total Receivables	27.2	33.7	48.2	52	52.1
Total Inventory
Total Other Current Assets
Total Current Assets	279	238	190	160	101
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	329	342	334	312	297
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	707	643	569	544	455
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	86.4	116	86.3	66.9	60.4
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	153	163	124	98.6	90.6
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	554	480	446	445	364
Total Liabilities & Shareholders' Equity	707	643	569	544	455
Total Common Shares Outstanding